Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Opthea Limited ( (AU:OPT) ) is now available.
Opthea Limited has announced a new application for the quotation of securities on the Australian Securities Exchange (ASX). This move involves the issuance of 347 ordinary fully paid securities, which were issued on March 6, 2025. The announcement signifies Opthea’s strategic efforts to enhance its financial flexibility and operational capacity, potentially impacting its market positioning and providing new opportunities for stakeholders.
More about Opthea Limited
Opthea Limited operates in the biotechnology industry, focusing on the development of therapies for eye diseases. The company is known for its innovative approaches to treating retinal disorders and aims to address significant unmet needs in the ophthalmology market.
YTD Price Performance: 9.09%
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $541.8M
For an in-depth examination of OPT stock, go to TipRanks’ Stock Analysis page.